Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,758 across all filing types
Latest filing 2024-12-13 Capital/Financing Update
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Partial Redemption of NCDs
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the partial redemption of Non-Convertible Debentures (NCDs) by the company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities) rather than a full financial report or earnings release. The document length is short (1427 characters) and it is an announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-12-13 English
Copy of Newspaper Publication
Regulatory Filings
2024-12-09 English
Newspaper Publication with respect to IEPF.
Regulatory Filings
2024-12-09 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) announcing that Torrent Pharmaceuticals has entered into an agreement to acquire three anti-diabetes brands from Boehringer Ingelheim. The content is a press release about a business acquisition agreement, not a full financial report or detailed financial statements. The document length is 3999 characters, which is relatively short and consistent with an announcement rather than a detailed report. There is no indication of financial results, audit information, or regulatory certifications. The key subject is the acquisition agreement, which fits the category of Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes through acquisition. Therefore, the appropriate classification is CAP with high confidence.
2024-12-04 English
Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) announcing that Torrent Pharmaceuticals has entered into an agreement to acquire three anti-diabetes brands from Boehringer Ingelheim. It includes a press release about the acquisition, market context, and company background. The document is short (3999 characters) and serves as an announcement of a capital transaction (acquisition of brands). There are no financial statements or detailed financial performance data, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a merger or takeover bid filing (MA or TAR) since it is an acquisition of brands, not a company merger or tender offer. The document fits best under Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through acquisition agreements. Therefore, the classification is CAP with high confidence.
2024-12-04 English
Announcement under reg 30
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about an order passed by the Income Tax Department imposing a penalty. It is a regulatory announcement about a legal/tax matter affecting the company, with no financial statements or detailed financial report included. The document is relatively short (2542 characters) and serves as an official notification to the stock exchanges. It does not contain an audit report, annual report, earnings release, or any detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.